|
BIO-key International, Inc. (BKYI) DCF Valuation
US | Industrials | Security & Protection Services | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
BIO-key International, Inc. (BKYI) Bundle
Whether you're an investor or analyst, this (BKYI) DCF Calculator is your go-to resource for accurate valuation. Loaded with real data from BIO-key International, Inc., you can easily adjust forecasts and observe the changes in real time.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.3 | 2.8 | 5.1 | 7.0 | 7.8 | 10.7 | 14.8 | 20.5 | 28.4 | 39.2 |
Revenue Growth, % | 0 | 25.1 | 80.29 | 37.26 | 10.46 | 38.28 | 38.28 | 38.28 | 38.28 | 38.28 |
EBITDA | -12.4 | -4.9 | -4.5 | -11.4 | -7.8 | -10.5 | -14.5 | -20.0 | -27.7 | -38.3 |
EBITDA, % | -545.79 | -172.87 | -88.64 | -162.01 | -101.19 | -97.73 | -97.73 | -97.73 | -97.73 | -97.73 |
Depreciation | 1.1 | .4 | .5 | .5 | .6 | 1.9 | 2.7 | 3.7 | 5.2 | 7.1 |
Depreciation, % | 50.43 | 15.05 | 10.05 | 7.78 | 7.61 | 18.18 | 18.18 | 18.18 | 18.18 | 18.18 |
EBIT | -13.5 | -5.3 | -5.0 | -11.9 | -8.4 | -10.7 | -14.8 | -20.5 | -28.3 | -39.1 |
EBIT, % | -596.22 | -187.92 | -98.7 | -169.79 | -108.8 | -99.74 | -99.74 | -99.74 | -99.74 | -99.74 |
Total Cash | .6 | 17.5 | 7.8 | 2.6 | .5 | 5.8 | 8.0 | 11.1 | 15.3 | 21.2 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .2 | .9 | 1.1 | 1.6 | 1.3 | 2.2 | 3.1 | 4.2 | 5.8 | 8.1 |
Account Receivables, % | 10.45 | 31.85 | 21.55 | 22.4 | 16.77 | 20.6 | 20.6 | 20.6 | 20.6 | 20.6 |
Inventories | .4 | .3 | 4.9 | 4.8 | .4 | 4.3 | 6.0 | 8.3 | 11.4 | 15.8 |
Inventories, % | 18.92 | 11.67 | 96.6 | 68.86 | 5.75 | 40.36 | 40.36 | 40.36 | 40.36 | 40.36 |
Accounts Payable | .9 | .2 | .4 | 1.1 | 1.3 | 1.9 | 2.7 | 3.7 | 5.1 | 7.1 |
Accounts Payable, % | 40.54 | 8.61 | 8.36 | 15.79 | 16.97 | 18.05 | 18.05 | 18.05 | 18.05 | 18.05 |
Capital Expenditure | .0 | .0 | .0 | -.1 | .0 | -.1 | -.1 | -.2 | -.3 | -.4 |
Capital Expenditure, % | -1.34 | -1.25 | -0.82167 | -1.17 | -0.01289506 | -0.92032 | -0.92032 | -0.92032 | -0.92032 | -0.92032 |
Tax Rate, % | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 |
EBITAT | -13.6 | -7.5 | -4.6 | -12.5 | -8.3 | -10.5 | -14.5 | -20.0 | -27.6 | -38.2 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -12.2 | -8.3 | -8.7 | -11.7 | -2.9 | -12.8 | -13.7 | -18.9 | -26.1 | -36.1 |
WACC, % | 22.73 | 22.73 | 20.88 | 22.73 | 22.43 | 22.3 | 22.3 | 22.3 | 22.3 | 22.3 |
PV UFCF | ||||||||||
SUM PV UFCF | -54.8 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -37 | |||||||||
Terminal Value | -181 | |||||||||
Present Terminal Value | -66 | |||||||||
Enterprise Value | -121 | |||||||||
Net Debt | 0 | |||||||||
Equity Value | -121 | |||||||||
Diluted Shares Outstanding, MM | 1 | |||||||||
Equity Value Per Share | -215.88 |
What You Will Receive
- Authentic BIO-key Data: Preloaded financials – encompassing revenue to EBIT – derived from actual and projected metrics.
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Adjustments: Automatic recalculations to evaluate the effects of changes on BIO-key's fair value.
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and in-depth projections.
- Efficient and Precise: Bypass the hassle of building models from the ground up while ensuring accuracy and adaptability.
Key Features
- Customizable Growth Metrics: Adjust essential parameters such as revenue projections, profit margins, and investment costs.
- Instant DCF Calculations: Quickly determines intrinsic value, net present value (NPV), and other financial metrics.
- High-Precision Valuation: Incorporates BIO-key International's (BKYI) actual financial data for accurate valuation results.
- Effortless Scenario Testing: Easily evaluate various assumptions and analyze their impacts on outcomes.
- Efficiency Booster: Save time by avoiding the complexities of creating detailed valuation models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered BIO-key International, Inc. (BKYI) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for BIO-key International, Inc. (BKYI)’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for BIO-key International, Inc. (BKYI)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters effortlessly to suit your financial analysis.
- Real-Time Adjustments: Observe immediate changes to BIO-key’s valuation as you tweak inputs.
- Preloaded Data: Comes equipped with BIO-key’s latest financial information for swift evaluations.
- Industry Approved: Favored by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Investors: Evaluate BIO-key International, Inc.'s (BKYI) market potential before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts for BIO-key.
- Startup Founders: Understand the valuation strategies applied to innovative tech companies like BIO-key.
- Consultants: Provide detailed valuation analyses and reports for clients considering BIO-key.
- Students and Educators: Utilize real-time data to learn and teach valuation principles related to BIO-key International, Inc. (BKYI).
What the Template Contains
- Pre-Filled Data: Contains BIO-key International, Inc.'s historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model featuring automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
- Key Financial Ratios: Evaluate BIO-key International, Inc.'s profitability, efficiency, and leverage.
- Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
- Clear Dashboard: Visuals and tables summarizing essential valuation results.